Zárate-Chavarría E

Idioma: Inglés [English version]
Referencias bibliográficas: 19
Paginas: s196-199
Archivo PDF: 254.06 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. US Department of Health and Human Services; US Department of Agriculture. 2015-2020 Dietary Guidelines for Americans. 8th ed. Washington, DC: US Dept of Health and Human Services; December 2015. Available in: http://www.health.gov/DietaryGuidelines

2. Valenzuela A, Ronco A. Fitoesteroles y fitoestanoles: aliados naturales para la protección de la salud cardiovascular. Rev Chil Nutr. 2004; 21 (S-1): 161-169.

3. Jia L, Betters JL. Yu L. Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and hepatic cholesterol transport. Annu Rev Physiol. 2011; 73: 239-259.

4. Muñoz JAM, Alvarado OUC, Encina ZC. Fitoesteroles y fitoestanoles; propiedades saludables. Horizonte Médico. 2011; 11: 93-100.

5. Huff MW. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis. Can J Clin Pharmacol. 2003; 10 (Supl. A): 26-32.

6. Fernandez ML, West KL. Mechanisms by which dietary fatty acids modulate plasma lipids. J Nutr. 2005; 135: 2075-2078.

7. Rong Y, Chen L, Zhu T, Song Y, Yu M, Shan Z et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ. 2013; 346: e8539.

8. Pascual V, Perez MP, Fernández JM, Solá R, Pallarés V, Romero SA et al. SEA/SEMERGEN consensus document 2019: Dietary recommendations in the prevention of cardiovascular. Disease Clin Investig Arterioscler. 2019; 31: 186-201.

9. Geiker NRW, Larsen ML, Dyerberg J, Stender S, Astrup A. Egg consumption, cardiovascular diseases and type 2 diabetes. Eur J Clin Nutr. 2018; 72: 44-56.

10. Backhed F. Meat-metabolizing bacteria in atherosclerosis. Nat Med. 2013; 19: 533-534.

11. Lundberg JO, Gladwin MT, Ahluwalia A, Benjamin N, Bryan NS, Butler A et al. Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol. 2009; 5: 865-869.

12. Moreno FB, León LM, Andrés EEM, Ordovás JM, Casasnovas JA, Peñalvo JL. Ingesta de fibra soluble e insoluble y factores de riesgo de síndrome metabólico y enfermedad cardiovascular en adultos de mediana edad: la cohorte AWHS. Nutr Hosp. 2014; 30: 1279-1288.

13. Harris WS, Mosaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr. 2009; 139: 804S-819S.

14. Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y et al. JELIS Investigators, Japan. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis. 2008; 200: 135-140.

15. Bhatt DL, Steg G, Miler M, Brinton EA, Jacobson TA, Ketchum SB et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019; 380: 11-22.

16. Bernasconi AA, Wiest MM, Lavie CJ, Milani RV, Laukkanen JA. Effect of omega-3 dosage on cardiovascular outcomes: an updated meta-analysis and meta-regression of interventional trials. Mayo Clin Proc. 2021; 96 (2): 304-313.

17. Coronado HM, Vega y León S, Gutiérrez TR, Vázquez FM, Radilla VC. Antioxidantes: perspectiva actual para la salud humana. Rev Chil Nutr. 2015; 42: 206-212.

18. Pandey KB, Rizv SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009; 2: 270-278.

19. Bernatova I. Biological activities of (−)-epicatechin and (−)-epicatechin-containing foods: Focus on cardiovascular and neuropsychological health. Biotech Adv. 2018; 36: 666-681.